Get the Stockscreener App
0.4993
0.16%
0.0008
After Hours:
.48
-0.0193
-3.87%
Mainz Biomed N V stock is traded at $0.4993, with a volume of 190.81K.
It is up +0.16% in the last 24 hours and up +0.00% over the past month.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
See More
Previous Close:
$0.4985
Open:
$0.499
24h Volume:
190.81K
Relative Volume:
2.01
Market Cap:
$6.25M
Revenue:
$895.50K
Net Income/Loss:
$-26.30M
P/E Ratio:
-0.00761
EPS:
-65.5728
Net Cash Flow:
-
1W Performance:
-17.39%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.4579
$0.50
1-Week Range:
$0.43
$0.60
52-Week Range:
$0.43
$0.7977
Mainz Biomed N V Stock (QUCY) Company Profile
Name
Mainz Biomed N V
Sector
Industry
Phone
-
Address
-
Compare QUCY vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QUCY
Mainz Biomed N V
|
0.4993 | 6.24M | 895.50K | -26.30M | 0 | -65.57 |
TMO
Thermo Fisher Scientific Inc
|
490.77 | 182.14B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
187.15 | 134.43B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
575.72 | 45.40B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
112.98 | 32.27B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
302.32 | 29.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Mainz Biomed N V Stock (QUCY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-25 | Initiated | Maxim Group | Buy |
| Nov-25-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-21-23 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-21-22 | Initiated | H.C. Wainwright | Buy |
Mainz Biomed N V Stock (QUCY) Latest News
Mainz Biomed Receives Nasdaq Notice on Bid Price - TipRanks
Lazar financing could give Mainz Biomed (NASDAQ: MYNZ) 95%+ stake and new direction - Stock Titan
Mainz Biomed Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nasdaq warns Mainz Biomed (MYNZ) over sub-$1.00 bid and possible delisting risk - Stock Titan
Growth Recap: How much upside does Mainz Biomed NV have2026 Major Catalysts & Weekly Momentum Picks - baoquankhu1.vn
Mainz Biomed N.V. (QUCY) Fundamental Analysis - Meyka
Mainz Biomed N.V. (QUCY) Competitors - Meyka
Top Mainz Biomed (QUCY) Competitors 2026 - MarketBeat
Block Trades: Can Mainz Biomed NV be recession proofMarket Trend Review & Short-Term High Return Strategies - baoquankhu1.vn
Trend Review: How does Mainz Biomed NV compare to its peersGold Moves & Low Risk Growth Stock Ideas - baoquankhu1.vn
Mainz Biomed changes ticker symbol to QUCY - MSN
QUCY Technical Analysis & Stock Price Forecast - Intellectia AI
QUCY Technical Analysis | Trend, Signals & Chart Patterns | MAINZ BIOMED NV (NASDAQ:QUCY) - ChartMill
Mainz Biomed (QUCY) Stock Chart and Price History 2026 - MarketBeat
Mainz Biomed (QUCY) Stock Forecast and Price Target 2026 - MarketBeat
Total cash dividends paid of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Published on: 2026-03-19 07:11:22 - baoquankhu1.vn
What is the current Price Target and Forecast for Mainz Biomed NV (QUCY) - Zacks Investment Research
Mainz Biomed N.V. Earnings and Revenue – NASDAQ:QUCY - TradingView
QUCY: Mainz Biomed NVPrice & Consenus Chart - Zacks Investment Research
Mainz Biomed (QUCY) Stock Trends and Sentiment 2026 - MarketBeat
Mainz Biomed receives $3M tranche from shareholder Lazar By Investing.com - Investing.com South Africa
All News for QUCY : Mainz Biomed NV - Zacks Investment Research
Mainz Biomed receives $3M tranche from shareholder Lazar - Investing.com
Quantum Cyber (NASDAQ: QUCY) backed by $6M pre-funded Lazar funding - Stock Titan
QUCY Forecast — Price Prediction for 2026. Should I Buy QUCY? - Intellectia AI
QUCY Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Dividend HistoryMainz Biomed NV (QUCY) - Zacks Investment Research
Mainz Biomed (QUCY) Stock Analysis Report | Financials & Insights - Benzinga
symbol__ Stock Quote Price and Forecast - CNN
Mainz Biomed (QUCY) Stock Price, News & Analysis - MarketBeat
QUCY : Mainz Biomed Nv Key Company Details - Zacks Investment Research
Dilution adjustment of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Operating income of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
EBIT of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Diluted net income available to common stockholders of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
EBITDA of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Operating expenses (excl. COGS) of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Cash from investing activities of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Diluted earnings per share (diluted EPS) of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Cash from operating activities of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Gross profit of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Pretax income of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Total debt of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Average basic shares outstanding of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Mainz Biomed NV (QUCY) - Zacks Investment Research
Free cash flow of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
After tax other income/expense of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Net debt of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Equity in earnings of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Total revenue of Mainz Biomed N.V. – NASDAQ:QUCY - TradingView
Mainz Biomed N V Stock (QUCY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.19%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):